At Emerging Markets, we like to keep our eye on new potentially disruptive sectors. We found Cannabis in 2010 and everyone laughed at us. Fast forward to today Cannabis has turned into a massive industry. We see psychedelics as the next Cannabis. Peter Thiel has backed several companies in this space, as the saying goes "follow the money". Enter SILO, a company new to market who has assembled a very impressive team. As the saying goes, "bet on the jockey"

Silicon Valley Billionaire Peter Thiel Backs Psychedelics Firm ATAI in $24 Million Funding Round
https://www.thecannabisinvestor.ca/silicon-valley-billionaire-peter-thiel-backs-psychedelics-firm-atai-in-24-million-funding-round/

First Psychedelic Drug Stock Hits $1 Billion In Debut After Upsized IPO

https://www.investors.com/news/compass-pathways-sees-544-million-valuation-first-psychedelic-drugs-ipo/

Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson's, and other rare neurological disorders. Silo's mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.

https://www.otcmarkets.com/stock/SILO/news/Silo-Pharma-Inc-Expands-Board-with-Appointment-of-Dr-Kevin-Muoz-MD-Announces-Application-to-Uplist-to-OTCQB-Market?id=276216

Client Updates Delivered
Straight To Your Inbox

Email: 
   
Confirm Email
   

SILO SECURITY DETAILS
Share Structure

Market CapĀ 

17,887,161

11/02/2020

Authorized Shares

100,000,000

09/30/2020

Outstanding Shares

85,176,956

09/30/2020

Restricted

76,815,921

09/30/2020

Unrestricted

8,361,035

09/30/2020

Held at DTC

5,757,181

09/30/2020

Float

6,291,035

09/30/2020

Par Value

0.0001

Market Value calculated only for respective security

Recent News

https://www.otcmarkets.com/stock/SILO/news/Silo-Pharma-Inc-SILO-Announces-Successful-Uplisting-To-the-OTCQB-Venture-Market?id=276907
https://www.otcmarkets.com/stock/SILO/news/Silo-Pharma-Inc-Enters-into-Option-Agreement-with-University-of-Maryland-Baltimore-for-Central-Nervous-System-Homing-Pep?id=276746
https://www.otcmarkets.com/stock/SILO/news/Silo-Pharma-Inc-Expands-Board-with-Appointment-of-Dr-Kevin-Muoz-MD-Announces-Application-to-Uplist-to-OTCQB-Market?id=276216

Must Read OTC Markets/SEC policy on stock promotion and investor protection

https://www.otcmarkets.com/learn/policy-on-stock-promotion
https://www.otcmarkets.com/learn/investor-protection
https://www.sec.gov/news/press-release/2017-79
https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html

Emerging Markets Consulting LLC has been paid 35,000 dollars by SILO Pharma. EMC is contracted to receive an additional 35,000 dollars. https://www.emergingmarketsllc.com/disclaimer/